Amedisys Inc. (NASDAQ:AMED) went up by 1.94% during the previous trading session, and it is maintaining the win ahead of Thursday’s trading session. The share price of the Medical Care Facilities giant went up by $204.84 to trade ended Thursday trading at $200.95. This is up from the $200.95 price recorded on Wednesday’s trading session. Thanks to this latest performance, AMED is closer to the higher price 52-week target of $240.00 and further from the lowest price target of $190.00. Its performance from the start of the year has also been positive, with AMED up by 22.72% year-to-date.
Amedisys Inc. (AMED) started the day trading at $202.81 and recorded an intraday high of $205.94. It also recorded an intraday low of $197.23 during Thursday’s trading session. Amedisys Inc. is a very active stock that recorded a trading volume that is less than -84.64% of the average daily trading volume on Thursday. The stock’s trading volume on Thursday was 221390, which is less than -84.64 of the total average daily trading volume of 408.77K.
Amedisys Inc. (NASDAQ:AMED) 2020 Performance Impressive
The increase in AMED’s stock price on Thursday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of AMED currently stands at $218.44, which is higher than the current trading price of the stock by 6.23%. However, AMED’s current trading price is -72.44% lower than the 52-week low price of $118.79. In terms of trading volume, Amedisys Inc. currently experienced healthy participation during the last trading session. 221390 shares of Amedisys Inc. were traded on the stock exchange on Thursday, which is less than -84.64% of the 408.77K average trading volume of the stock.
The performance of the stock has been positive over the past year. AMED’s performance over the past one year has seen it surge by 69.58%, while the stock has gone up by 19.21% in the last six months. The quarterly performance of AMED currently stands at 10.99%, and it is up by 16.11% in the last month. The only negative figure was from the weekly performance, which currently reads -0.38%. At the time of writing AMED’s report, the company has a total market cap of $6.68B, making it one of the largest publicly-traded companies in the world.Amedisys Inc. also has over 21300 employees all over the world.
AMED Insider Activities
For Amedisys Inc., insiders hold 91.40% of all company shares. The insider transactions over the past six months are up by 47.80%. During that period, insiders bought 173,682 shares in 37 transactions. In that same period, insiders sold 109,411 of their shares in 99 transactions. After these transactions, insiders at Amedisys Inc. now hold 362.97k shares, which is over 90.99% of the total company stocks. Institutional investors currently hold a large chunk of the AMED shares, as they control 1.12% of the company’s total stock.
AMED Fundamental Analysis
For Amedisys Inc., the stock’s diluted earnings per share (EPS) stands at 3.85. In the coming year, analysts expect the EPS to be 5.80. The EPS growth will up over the next five years to 13.88% after surging by 57.60% in the previous five years. In terms of revenue, Amedisys Inc.’s quarterly sales (YOY) is growing at 0.84, which is lower than the average annual revenue of 57.60% over the past half a decade.
The Return on Investment (ROI) on Amedisys Inc.’s stock currently stands at 15.30%, and it has a net profit margin of 6.40%. The operating margin of the company is 8.90%, and its gross margin is 41.40%.
AMED Analysts Prediction
and Robert W. Baird reiterate their Outperform position on the stock ($140 and $160).
Deutsche Bank and Mizuho also believe that Amedisys Inc.’s stock is outperforming at the moment.
At the moment, Amedisys Inc.’s Total Debt to Equity ratio stands at 0.58, and they have a long-term Debt to Equity ratio of 0.56.
AMED Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of AMED currently stands at 6.56%, while the SMA50 is 9.55%. The biggest one is the SMA200, which is currently reading 20.10% ahead of Thursday’s trading session. The Relative Strength Index of this stock is 60.92, while its price to earnings ratio (P/E) is 53.19.